Stockreport

Merck's Keytruda extends lung cancer survival in two trials [Reuters (UK)]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Merck's Keytruda extends lung cancer survival in two trials | Reuters 4 Min Read CHICAGO (Reuters) - Merck & Co’s immunotherapy Keytruda improved survival as a stand-alo [Read more]